1. Market Research
  2. > Healthcare Market Trends
  3. > Image-guided Surgery and Robot-assisted Surgery Market in Asia-Pacific

Developed Markets Experiment with the Latest Technologies in Surgery

This research service covers the revenues and trends in the Asia-Pacific (APAC) image-guided surgery (IGS) and robot-assisted surgery (RAS) market. Higher disposable income, penetration of health insurance, and improvement in overall quality of life necessitate the need for quality healthcare services. This has led to investment in assistive technologies by private hospitals. There is also rising demand for efficient and patient-safety treatment protocols that could be achieved using IGS and RAS. With innovations in healthcare, there has been a significant transition from conventional and minimally invasive surgeries to use of assistive technologies such as IGS and RAS.

Methodology

• The majority of the quantitative and qualitative information contained in this research service was acquired through primary research conducted with manufacturers, distributors, and key opinion leaders for image-guided surgery (IGS) and robot-assisted surgery (RAS) market. Most interviews were conducted with product managers and marketing managers.
• The analysis contained in this research service is based on the following.
oInformation collected through discussions with market participants and from secondary sources—government, industry associations, companies, and other web sites and credible sources.
oPublic announcements and plans by OEMs, suppliers, new entrants, and distributors.
oFrost & Sullivan’s published research services and market and technology expertise.
• Forecasts are guided by data and analysis based on the market dynamics. When specific market sizes were unavailable, estimates were extrapolated using a combination of secondary and primary research.
• Industry-specific information obtained include:
oRevenue breakdowns by technology segments and regions specific to the market
oCompany revenues, market share estimates, and projected growth rates
oMarket information, including customers, regional, and technology trends
oMarket drivers, restraints, and challenges

Key Findings

• The total market for image-guided surgery (IGS) and robot-assisted surgery (RAS) in Asia-Pacific (APAC) was worth $Xmillion in 2013 and is expected to reach $X million in 2018, expanding at a CAGR of X%.
• Japan accounted for about X% of the total market revenue in 2013, followed by Taiwan accounting for X%. Other APAC countries held X% share that year.
• IGS has become well-accepted in most APAC countries. It is commonly used for neuro and spinal surgeries.
• RAS has been gaining slow acceptance in most APAC countries. Regulatory environment and lower reimbursement are key deterrents to growth.
• RAS for multi-functional surgeries account for more than X% of the total RAS revenue.
• Adoption of IGS and RAS amongst healthcare providers varies considerably among the countries as well as among the public and private sectors. While Japan, Taiwan, South Korea, and Australia have high level of adoption of the technologies, most countries across the region are still in the early phase of adoption.
• There continues to be significant confusion and apprehension regarding the safety of and the accuracy of the prognosis provided by RAS technologies.
• Lack of surgeons specializing in IGS and RAS and constrained hospital budgets continue to dampen the adoption of assistive technologies in the region.

Scope and Segmentation

Geographic Segmentation: Asia-Pacific (APAC)
Study Period: 2011–2018
Base Year: 2013
Forecast Period: 2014–2018
Monetary Unit: US Dollars

Revenues for the total market are derived from two segments: IGS and RAS.
IGS: IGS in this study represents image guidance and navigation systems. Devices using sophisticated methodologies of image acquisition, computing, processing, and rendering to generate 3D reconstructions of the human anatomy.
RAS: RAS represents systems that use robotic technology to carry out prostate, stomach, cardiac, ortho, spine, and neurological procedures.
Price is defined as the average selling price of IGS and RAS systems.
Revenue is the income generated for the manufacturers from IGS and RAS systems sold to end users.
Asia-Pacific (APAC) includes Australia, South Korea, Japan, Taiwan, and SE Asia.
SE Asian countries inlude Singapore, Malaysia, Thailand, Indonesia, the Philippines, and Vietnam.

CEO’s Perspective

1. Proven benefits of IGS and RAS technologies are driving volume adoption in developed and developing APAC countries at a moderate rate.
2. The views of surgeons and patients are vital in adoption of the technologies.
3. Budget constraints along with lack of skilled workforce deter hefty investment in RAS by healthcare providers.
4. IGS is an attractive alternative business model for medical imaging companies.
5. Several robots, currently being developed for various applications, will enter the market during the next five years.

Key Questions This Study Will Answer

What is the market size and potential for IGS and RAS surgeries? How long will it continue to grow, and at what rate?
Are the existing competitors structured correctly to meet customer needs? What is the role of domestic manufacturers of IGS and RAS systems, and how does it impact the market?
What is the greatest challenge faced by the IGS and RAS market and how can it be overcome?
Which are the major countries for the market, and what are the important trends for each application of IGS and RAS?
Are the products offered in IGS and RAS currently meeting customer needs, or is additional development needed?
Are manufacturers in the IGS and RAS market ready to work independently, or do they need partnerships to take their business to the next level?

Table Of Contents

Image-guided Surgery and Robot-assisted Surgery Market in Asia-Pacific
Table of Contents

1. Executive Summary
o Key Findings
2. Market Overview
3. Competitive Playbook
o New Market Opportunities
o Mergers and Acquisitions, and Partnership Assessment
4. Drivers, Restraints, and Trends—Total IGS and RAS Market
5. Forecasts and Trends—Total IGS and RAS Market
o Forecast Assumptions
o Revenue Forecast
o Pricing Analysis
o PESTLE Analysis
6. Market Share and Competitive Analysis
7. IGS Segment Breakdown
8. RAS Segment Breakdown
9. IGS and RAS Market—Breakdown by Country
o Australia Breakdown
o South Korea Breakdown
o Taiwan Breakdown
o Japan Breakdown
o SE Asia Breakdown
10. Key Companies to Watch
11. IGS and RAS Market—The Last Word
12. Appendix



List of Exhibits

• Total IGS and RAS Market: Market Engineering Measurements, Asia-Pacific, 2013
• Total IGS and RAS Market: Market Segmentation, Asia-Pacific, 2013
• Total IGS and RAS Market: Percent Sales Breakdown, Asia-Pacific, 2013
• Total IGS and RAS Market: Key Competitor Product and Application in IGS, Asia-Pacific, 2013
• Total IGS and RAS Market: Competitor Product and Application in RAS, Asia-Pacific, 2013
• Total IGS and RAS Market: Growth Influencing Factors, Asia-Pacific, 2013 and 2018
• Total IGS and RAS Market: Distribution Structure, Asia-Pacific, 2013
• Total IGS and RAS Market: New Market Opportunities, Asia-Pacific, 2013
• Total IGS and RAS Market: Recent Mergers and Acquisitions, and Partnership Assessment, 2013
• Total IGS and RAS Market: Key Market Drivers, Asia-Pacific, 2014-2018
• Total IGS and RAS Market: Key Market Restraints, Asia-Pacific, 2014-2018
• Total IGS and RAS Market: Asia-Pacific, 2013
• Total IGS and RAS Market: Revenue Forecast, Asia-Pacific, 2011-2018
• Total IGS and RAS Market: Percent GDP Spend on Healthcare versus Healthcare Spend on Medical Technologies, Asia-Pacific, 2013
• Total IGS and RAS Market: Pricing Analysis, Asia-Pacific, 2013
• Total IGS and RAS Market: PESTLE Analysis, Asia-Pacific, 2013
• Total IGS and RAS Market: Competitive Structure, Asia-Pacific, 2013
• IGS Segment: Percent Sales Breakdown, Asia-Pacific, 2013
• IGS Segment: Revenue Forecast, Asia-Pacific, 2011-2018
• IGS Segment: Revenue Forecast by Country, Asia-Pacific, 2011-2018
• IGS Segment: Market Structure by Tier, 2013
• RAS Segment: Percent Sales Breakdown, Asia-Pacific, 2013
• RAS Segment: Revenue Forecast, Asia-Pacific, 2011-2018
• RAS Segment: Revenue Forecast by Application, Asia-Pacific, 2011-2018
• RAS Segment: Revenue Forecast by Country, Asia-Pacific, 2011-2018
• Percent of Sales RAS Segment: Asia-Pacific, 2013
• RAS Segment: Company Market Share Analysis of Participants, Asia-Pacific, 2013
• IGS Segment: Revenue Forecast, Australia, 2011-2018
• RAS Segment: Revenue Forecast, Australia, 2011-2018
• RAS Segment: Revenue Forecast by Application, Australia, 2011-2018
• IGS Segment: Revenue Forecast, South Korea, 2011-2018
• RAS Segment: Revenue Forecast, South Korea, 2011-2018
• RAS Segment: Revenue Forecast by Application, South Korea, 2011-2018
• IGS Segment: Revenue Forecast, Taiwan, 2011-2018
• RAS Segment: Revenue Forecast, Taiwan, 2011-2018
• RAS Segment: Revenue Forecast by Application, Taiwan, 2011-2018
• IGS Segment: Revenue Forecast, Japan, 2011-2018
• RAS Segment: Revenue Forecast, Japan, 2011-2018
• RAS Segment: Revenue Forecast by Application, Japan, 2011-2018
• IGS Segment: Revenue Forecast, SE Asia, 2011-2018
• RAS Segment: Revenue Forecast, SE Asia, 2011-2018
• RAS Segment: Revenue Forecast by Application, SE Asia, 2011-2018
• Total IGS and RAS Market: Number of Hospitals Adopting RAS, Asia-Pacific, 2012-2018
• Decision Support Database: Population Aged Above 65, Asia-Pacific, 2007-2017
• Decision Support Database: Total Healthcare Expenditure, Asia-Pacific, 2008-2018
• Decision Support Database: Per Capita Healthcare Expenditure, Asia-Pacific, 2008-2018
• Decision Support Database: Percentage of Public Healthcare Expenditure in Total Healthcare Expenditure, Asia-Pacific, 2008-2018
• Decision Support Database: Percentage of Private Healthcare Expenditure in Total Healthcare Expenditure, Asia-Pacific, 2008-2018
• Decision Support Database: Percent Healthcare Expenditure in GDP, Asia-Pacific, 2008-2018

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.